Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non–Small Cell Lung Cancer

IMPORTANCE: There is a need to tailor treatments to patients who are most likely to derive the greatest benefit from them to improve patient outcomes and enhance cost-effectiveness of cancer therapies. OBJECTIVE: To compare overall survival (OS) between patients with a current or former history of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Popat, Sanjay, Liu, Stephen V., Scheuer, Nicolas, Gupta, Alind, Hsu, Grace G., Ramagopalan, Sreeram V., Griesinger, Frank, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133943/
https://www.ncbi.nlm.nih.gov/pubmed/35612853
http://dx.doi.org/10.1001/jamanetworkopen.2022.14046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133943/
https://www.ncbi.nlm.nih.gov/pubmed/35612853
http://dx.doi.org/10.1001/jamanetworkopen.2022.14046

Ejemplares similares